Effects of a Multimodal and Multidimensional Intervention on Urinary Incontinence in Young Nulliparous Female Athletes.

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age15-40
SponsorCentre Hospitalier Universitaire de Saint Etienne

About this trial

A prevalence of urinary incontinence ranging from 5.7% to 80% has been observed in young nulliparous athletes during their activity.

The usual recommendations for managing adult women do not seem to be transferable.

Young nulliparous athletes need specific educational and behavioral interventions and an alternative to pelvic floor muscle strengthening.

A multimodal and multidimensional intervention for athletes and coaches combining specific pelvic health education and strengthening of lumbopelvic-abdominal stability appears to be an innovative and optimal solution for reducing the symptoms of urinary incontinence in young nulliparous women who participate in athletics.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Female subject, nulliparous

Member of an athletics club affiliated with the French Athletics Federation (FFA)

At least 15 years old at the start of the study and belonging to the U16/U18/U20/U23 categories (born between January 1, 2005, and September 1, 2011)

Having internet access

Disqualifiers

Any individual deprived of their liberty or subject to legal protection (guardianship, curatorship, or protective supervision).

A pregnant woman, a woman who has been pregnant, or a woman planning a pregnancy within the last nine months.

Any individual unable to understand the purpose and conditions of the study.

Any individual unable to give their consent.

Trial design

Design model

Sequential

Treatments tested in this trial

  • Combined pelvic health education and lumbar-pelvic-abdominal stability strengthening programme.

    Other intervention

    The intervention will consist of participants: i) reviewing educational content (8 educational videos online) ii) participating in two in-person sessions at the athletics club and performing lumbar-pelvic-abdominal stability exercises iii) learning and implementing recommendations for empowering themselves in pelvic health management. iv) complete reports in 6 questionnaires during follow-up.

  • Usual activities

    Other intervention

    Collection of data on routine activities

Treatment groups

198 Participants
are divided into 2 treatment groups
Group A: Control conditionActive comparator 1 intervention
Group B: Interventional conditionExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Urinary incontinence symptoms

Severity of urinary incontinence symptoms as measured by the ICIQ-UI-SF score (International Consultation on Incontinence Questionnaire - Short Form for Urinary Incontinence). Scores typically range from 0 to 21. The higher the score, the more severe the urinary incontinence.

Time frame
Week 1, 7, 13, 19, 25, 31

Secondary outcomes

1

The program's effects on the prevalence of urinary incontinence

The program's effects on the prevalence of urinary incontinence will be measured using the ICIQ-UI-SF questionnaire, with a dichotomous interpretation of the score: 0 = continent, ≥1 = incontinent.

Time frame
Week 1, 7, 13, 19, 25, 31
2

Effects of the intervention on athletes' knowledge of the pelvic-perineal region

A questionnaire we have developed will measure the effects of the intervention on athletes' knowledge of the pelvic and perineal region. It will consist of 10 questions. This outcome will be assessed by comparing the mean number of correct answers (on a scale of 0 to 10) within and between groups.

Time frame
Week 1, 31
3

The program's effects on associated pelvic and perineal symptoms

The ODS-S questionnaires measure associated pelvic and perineal symptoms. This criterion will be assessed by comparing the mean total scores (on a scale of 0 to 20) within and between groups.

Time frame
Week 1, 31
4

The program's effects on urinary dysfunction.

Section C of the LURN-SI29 questionnaire, which assesses urinary dysfunction. This criterion will be evaluated by comparing the mean total scores (on a scale of 0 to 20) within and between groups.

Time frame
Week 1, 31

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.